肘下动脉病变的血管腔内治疗:单中心初步经验
本研究回顾性分析了19例因严重手部缺血接受25次肘下动脉腔内血运重建的连续病例。技术成功率为88%(22/25),并发症6例(5例轻微,1例严重),14例随访患者中12例临床成功,7例溃疡患者中5例创面愈合。结论认为肘下动脉腔内血运重建治疗严重手部缺血有效且安全。
要点
- 肘下动脉腔内血运重建技术成功率达88%(22/25),无与适应证或基线血管病变相关的显著差异。
- 严重手部缺血患者中,随访可及的14例中12例获临床成功,7例溃疡中5例创面愈合。
- 并发症共6例,其中5例为轻微、1例为严重,提示该策略总体安全。
核心结论
- 肘下动脉闭塞性病变的腔内血运重建是治疗严重手部缺血有效且安全的策略。
研究设计与样本
- 回顾性单中心研究,纳入2010年10月至2017年6月期间19例严重手部缺血患者(平均年龄63岁,12例男性),共19条手臂接受25次介入治疗。
- 入路根据靶血管选择顺行肱动脉、逆行桡动脉或瘘管/移植物通路,使用4-F或5-F鞘。
- 采用0.018英寸亲水微导丝进行内膜下或内膜内再通,在0.014英寸导丝上使用低剖面球囊行血管成形术。
主要发现
- 技术成功率为88%(22/25次手术),技术成功定义为成功穿越/扩张病变且残余狭窄<30%。
- 并发症发生于6次手术,其中5例为轻微并发症、1例为严重并发症。
- 14例有随访数据的患者中12例获临床成功;7例溃疡患者中5例创面愈合。
关键数值与推荐
- 技术成功定义:成功穿越/扩张病变,残余狭窄<30%。
- 临床成功定义:疼痛和/或窃血症状改善。
- 技术成功率88%(22/25),并发症6例(5例轻微、1例严重)。
临床怎么用
- 对严重手部缺血患者,可考虑经顺行肱动脉、逆行桡动脉或瘘管/移植物入路行肘下动脉腔内血运重建。
- 使用0.018英寸亲水微导丝和低剖面球囊进行再通与扩张是可行的技术选择。
- 术后需关注疼痛和窃血症状改善及溃疡愈合情况以评估临床成功。
局限性
- 本研究为单中心回顾性研究,样本量小(19例患者、25次手术),随访数据不完整(仅14例有随访)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To evaluate the technical success, clinical success, and complication rates of endovascular revascularization for below-the-elbow (BTE) peripheral artery disease. Materials and Methods: A retrospective review was performed of 19 patients (mean age 63 years; 12 men) with critical hand ischemia (CHI) who underwent 25 interventions in 19 arms between October 2010 and June 2017. Access was attained using 4-F or 5-F sheaths via antegrade brachial, retrograde radial, or fistula/graft access routes depending on the target vessel. A 0.018-inch hydrophilic microwire was used for intimal or subintimal recanalization. Angioplasty was performed over a 0.014-inch guidewire using low-profile balloons. The primary endpoint of the study was technical success, defined as successful lesion crossing/dilation, with residual stenosis <30%. Clinical success referred to improvement in pain and/or steal symptoms. Results: Technical success was achieved in 88% (22 of 25 procedures), with no significant difference in outcome associated with indications or baseline vessel disease. Complications occurred in 6 cases, of which 5 were minor and 1 was major. Clinical success was achieved in 12 of 14 patients with available follow-up; 5 of 7 patients with ulcers experienced wound healing. Conclusion: Endovascular revascularization for BTE occlusive disease is an effective and safe strategy for treating CHI.
引用
- Chen JX, Levin LS, Mantell MP, et al. Endovascular Therapy for Below-the-Elbow Arterial Disease: An Initial Single-Center Experience. J Endovasc Ther. 2019. PMID: 31179815. doi:10.1177/1526602819854167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。